Behandlingen af patienter med svære nyreproblemer skal indledes med forsigtighed, og der skal udvises særlig forsigtighed, hvis dosen øges.
In patients who have severe problems with their kidneys, treatment with Volibris should be started with caution, and a dose increase should be carried out with particular care.